Prevenzione primaria della malattia cardiovascolare: c’è bisogno di un’aspirina?
The efficacy of antiplatelet treatment with aspirin in the primary prevention of major cardiovascular events was questioned during 2018, following a new series of trials that we summarize here in a quick synoptic overview. The three studies involved are the ASPREE trial, the ASCEND study and the ARR...
Salvato in:
| Autori principali: | , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
AboutScience Srl
2019-09-01
|
| Serie: | Giornale di Clinica Nefrologia e Dialisi |
| Accesso online: | https://journals.aboutscience.eu/index.php/gcnd/article/view/535 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|